RxDoctor Payments Data

Jonathan Finkelstein, MD

Interventional Pain Medicine · Babylon, NYNPI 1790930113

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 68.5% of it on its own, with 33 other manufacturers making up the rest.

$11,418in general payments, 2019–2025

Across 175 payments — averaging $65.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Pacira Pharmaceuticals Incorporated$569
  • Medtronic$368
  • Relievant Medsystems, Inc.$343
  • Biotronik NRO, Inc.$322
  • Scilex Pharmaceuticals Inc.$274
  • plus $2K from 28 others

What the payments were for

  • Consulting fees$3,20028%
  • Travel & lodging$3,68532%
  • Food & beverage$4,53340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,418 in reported general payments places this provider in the 75th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$593,918
Medicare patients
305
Services billed
9,229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin18$908
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$699
Gabapentin26$317
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$307
Oxycodone Hcl15$234
Tizanidine Hcl17$146
Morphine Sulfate ErMorphine Sulfate14$80
Methylprednisolone11$48
Diazepam19$15

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Babylon

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →